Literature DB >> 19716997

Posttraumatic stress disorder and stress-related disorders.

Arieh Y Shalev1.   

Abstract

Posttraumatic stress disorder (PTSD) is a prevalent anxiety disorder. Symptoms present shortly after an exposure to a traumatic event, abate with time in the majority of those who initially express them, and leave a significant minority with chronic PTSD. PTSD may be treated with pharmacotherapy or psychotherapy. Treatment of the early expressions of the disorder constitutes a separate domain of theory and research. Treatment of chronic PTSD often stabilizes the condition but rarely produces stable remission. This article reviews the empirical evidence on the treatment of acute and chronic PTSD, outlines similarities and differences between PTSD and other Axis I disorders, evaluates new therapeutic approaches, and discusses the implications of current knowledge for the forthcoming DSM-V.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19716997      PMCID: PMC2746940          DOI: 10.1016/j.psc.2009.06.001

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN: 0193-953X


  112 in total

Review 1.  Dissemination of exposure therapy in the treatment of posttraumatic stress disorder.

Authors:  Shawn P Cahill; Edna B Foa; Elizabeth A Hembree; Randall D Marshall; Nitsa Nacash
Journal:  J Trauma Stress       Date:  2006-10

2.  The Cape Town consensus on posttraumatic stress disorder: introduction.

Authors:  Dan J Stein; J Zohar
Journal:  CNS Spectr       Date:  2009-01       Impact factor: 3.790

3.  Comparison of two treatments for traumatic stress: a community-based study of EMDR and prolonged exposure.

Authors:  G Ironson; B Freund; J L Strauss; J Williams
Journal:  J Clin Psychol       Date:  2002-01

4.  An evaluation of three brief programs for facilitating recovery after assault.

Authors:  Edna B Foa; Lori A Zoellner; Norah C Feeny
Journal:  J Trauma Stress       Date:  2006-02

Review 5.  Psychological treatments for chronic post-traumatic stress disorder. Systematic review and meta-analysis.

Authors:  Jonathan I Bisson; Anke Ehlers; Rosa Matthews; Stephen Pilling; David Richards; Stuart Turner
Journal:  Br J Psychiatry       Date:  2007-02       Impact factor: 9.319

Review 6.  Disability and quality of life in post-traumatic stress disorder: impact of drug treatment.

Authors:  Soraya Seedat; Christine Lochner; Bavanisha Vythilingum; Dan J Stein
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

7.  Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial.

Authors:  P Tucker; R Zaninelli; R Yehuda; L Ruggiero; K Dillingham; C D Pitts
Journal:  J Clin Psychiatry       Date:  2001-11       Impact factor: 4.384

Review 8.  Prazosin for treatment of nightmares related to posttraumatic stress disorder.

Authors:  Heather R Taylor; Maisha Kelly Freeman; Marshall E Cates
Journal:  Am J Health Syst Pharm       Date:  2008-04-15       Impact factor: 2.637

Review 9.  Early predictors of posttraumatic stress disorder.

Authors:  Richard A Bryant
Journal:  Biol Psychiatry       Date:  2003-05-01       Impact factor: 13.382

10.  Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study.

Authors:  Murray B Stein; Neal A Kline; Jeffrey L Matloff
Journal:  Am J Psychiatry       Date:  2002-10       Impact factor: 18.112

View more
  22 in total

1.  Incidence and predictors of acute psychological distress and dissociation after motor vehicle collision: a cross-sectional study.

Authors:  Gemma C Lewis; Timothy F Platts-Mills; Israel Liberzon; Eric Bair; Robert Swor; David Peak; Jeffrey Jones; Niels Rathlev; David Lee; Robert Domeier; Phyllis Hendry; Samuel A McLean
Journal:  J Trauma Dissociation       Date:  2014

2.  The glucocorticoid receptor-FKBP51 complex contributes to fear conditioning and posttraumatic stress disorder.

Authors:  Haiyin Li; Ping Su; Terence Ky Lai; Anlong Jiang; Jing Liu; Dongxu Zhai; Charlie Tg Campbell; Frankie Hf Lee; WeiDong Yong; Suvercha Pasricha; Shupeng Li; Albert Hc Wong; Kerry J Ressler; Fang Liu
Journal:  J Clin Invest       Date:  2020-02-03       Impact factor: 14.808

3.  Post traumatic stress disorder.

Authors:  Jyoti Prakash; A Saha; R C Das; Kalpana Srivastava; R Shashikumar
Journal:  Med J Armed Forces India       Date:  2015-06-17

Review 4.  LINE-1 retrotransposons in healthy and diseased human brain.

Authors:  Nicole A Suarez; Angela Macia; Alysson R Muotri
Journal:  Dev Neurobiol       Date:  2017-12-29       Impact factor: 3.964

5.  The long-term psychological sequelae of orofacial injury.

Authors:  Shirley M Glynn; Vivek Shetty
Journal:  Oral Maxillofac Surg Clin North Am       Date:  2010-05       Impact factor: 2.802

6.  [Trauma and stressor-related disorders: diagnostic conceptualization in DSM-5].

Authors:  H P Kapfhammer
Journal:  Nervenarzt       Date:  2014-05       Impact factor: 1.214

7.  Psychological Consequences of Maxillofacial Trauma in the Indian Population: A Preliminary Study.

Authors:  Balasubramanian Krishnan; Ravi Philip Rajkumar
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2017-07-19

8.  Effects of a post-shock injection of the kappa opioid receptor antagonist norbinaltorphimine (norBNI) on fear and anxiety in rats.

Authors:  Benjamin Rogala; Yonghui Li; Sa Li; Xiaoyu Chen; Gilbert J Kirouac
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

9.  Ethnomedicine and ethnobotany of fright, a Caribbean culture-bound psychiatric syndrome.

Authors:  Marsha B Quinlan
Journal:  J Ethnobiol Ethnomed       Date:  2010-02-17       Impact factor: 2.733

10.  Traumatic stress history interacts with sex and chronic peripheral inflammation to alter mitochondrial function of synaptosomes.

Authors:  Gladys A Shaw; Molly M Hyer; Imogen Targett; Kimaya R Council; Samya K Dyer; Susie Turkson; Chloe M Burns; Gretchen N Neigh
Journal:  Brain Behav Immun       Date:  2020-05-07       Impact factor: 19.227

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.